The fellows describe the challenging moments that brought them to select cardiology as their specialty.
Last week, CardioMEMS failed to get approval from an FDA advisory panel for treating heart failure based on uncertainty regarding the benefit; the advisory panel also raised concerns about study bias. This intracardiac device measures pulmonary artery pressures that clinicians can use (in addition to other clinical signals, such as weight gain) to select therapies…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
For our new series at CardioExchange, “Follow the Fellows,” we have invited physicians from various cardiology fellowship programs to document their course through their training. In this post, the fellows describe how they chose their fellowship programs. You can read their earlier posts here and here. A Long and Winding Road by Erica Spatz,…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Several Cardiology Fellows who are attending AHA.11 this week are blogging together on CardioExchange. The Fellows include Revathi Balakrishnan, Eiman Jahangir, John Ryan (moderator), and Amit Shah. Read the previous post here. This is their final post. See their complete coverage at the bottom of this post and in this review of our AHA coverage. Readers,…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Impressive safety and efficacy data on evacetrapib—but it’s too early give odds on whether it’s a true wonder drug or a nightmare like its fellow CETP inhibitor, torceptrapib
One of the best parts of this conference has been the opportunity to hear experts on the panels dissect and interpret the data following the presentations.
Several Cardiology Fellows who are attending AHA.11 this week are blogging together on CardioExchange. The Fellows include Revathi Balakrishnan, Eiman Jahangir, John Ryan (moderator), and Amit Shah. Read the previous post here. Check back often to learn about the biggest buzz in Orlando. The many studies and sessions devoted to depression and heart disease at AHA…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Several Cardiology Fellows who are attending AHA.11 this week are blogging together on CardioExchange. The Fellows include Revathi Balakrishnan, Eiman Jahangir, John Ryan (moderator), and Amit Shah. Read the previous post here. Check back often to learn about the biggest buzz in Orlando. Tuesday, I heard the presentation of the Practice-Based Opportunities for Weight Reduction (POWER)…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Several Cardiology Fellows who are attending AHA.11 this week are blogging together on CardioExchange. The Fellows include Revathi Balakrishnan, Eiman Jahangir, John Ryan (moderator), and Amit Shah. Read the previous post here. Check back often to learn about the biggest buzz in Orlando. This is the last day of the conference for me. While I am…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Removing copays increased adherence, decreased events, and saved the sponsoring insurance company a tidy sum. So are the issues with insurance-sponsored studies different from those with pharmaceutical-sponsored ones?
